These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

199 related items for PubMed ID: 12599530

  • 1. [Antimicrobial susceptibility and beta-lactamase types among clinical isolates during January and February 2000 in the Kinki area of Japan].
    Yamasaki K, Nishio H, Komatsu M, Satoh K, Yamashita T, Washidu R, Shimakawa K, Kinoshita S, Ura T, Aihara M.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():65-78. PubMed ID: 12599530
    [Abstract] [Full Text] [Related]

  • 2. [Antimicrobial susceptibility and prevalence of beta-lactamase producing clinical isolates in southern Kyushu. The results of collaborative study from 1999 to 2000].
    Nakasone I, Onaga S, Fukunaga H, Saitoh H, Yamane N, Sato Y.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():95-110. PubMed ID: 12599533
    [Abstract] [Full Text] [Related]

  • 3. [Antimicrobial susceptibility and beta-lactamase productivity of recent clinical isolates during the period between December 1999 and February 2000].
    Notake S, Nakamura Y, Yanagisawa H, Haketa M, Ide K, Nagai K, Kakegawa J, Shiozawa J, Kobayashi S, Shimazaki Y, Naitoh M, Toda K, Fujiki K, Okimura Y, Okabe T.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():111-8. PubMed ID: 12599534
    [Abstract] [Full Text] [Related]

  • 4. [Antimicrobial susceptibility and beta-lactamase producibility of bacteria clinically isolated during the period from December 1999 to February 2000].
    Abe M, Takaichi F, Amano H, Tazawa S, Satoh T, Nishizawa M, Takagi T, Miyamoto T.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():54-64. PubMed ID: 12599529
    [Abstract] [Full Text] [Related]

  • 5. [Drug sensitivity and beta-lactamase producibility of various types of bacteria clinically isolated during the period from December 1999 to February 2000].
    Hashimoto K, Kinosita C, Yoshinaga H, Sonda Y, Itoyama T, Oyamada K, Kajimura K, Kondou M, Sagawa K, Ouno T, Kawamoto K, Souda K, Hara K, Kakihara M, Tanaka T, Ryutou M, Shichiji A, Nakashima K, Ishibashi K, Tabira R, Yamamoto S, Nishida M, Tsutsumi Y.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():86-94. PubMed ID: 12599532
    [Abstract] [Full Text] [Related]

  • 6. [Beta-lactamase activity and susceptibilities to antibiotics among some species of bacteria isolated from medical institution between December 1999 and February 2000].
    Tanimoto A, Sadahisa K, Hayashibara T, Yamane Y, Adachi Y, Karino K, Yamauchi Y, Umeki F, Yasunaga M, Moriki S.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():79-85. PubMed ID: 12599531
    [Abstract] [Full Text] [Related]

  • 7. [beta-lactamase-producing activity and antimicrobial susceptibility of major pathogenic bacteria isolated from clinical samples. Japan beta-lactamase Research Group].
    Oguri T, Igari J, Hiramatsu K, Watanabe A, Inoue M, Abe M, Yamane N, Aihara M, Hashimoto H, Japan Beta-Lactamase Research Group.
    Jpn J Antibiot; 2002 Sep; 55 Suppl A():1-28. PubMed ID: 12599526
    [Abstract] [Full Text] [Related]

  • 8. Production of CTX-M-3 extended-spectrum beta-lactamase and IMP-1 metallo beta-lactamase by five Gram-negative bacilli: survey of clinical isolates from seven laboratories collected in 1998 and 2000, in the Kinki region of Japan.
    Yamasaki K, Komatsu M, Yamashita T, Shimakawa K, Ura T, Nishio H, Satoh K, Washidu R, Kinoshita S, Aihara M.
    J Antimicrob Chemother; 2003 Mar; 51(3):631-8. PubMed ID: 12615865
    [Abstract] [Full Text] [Related]

  • 9. Nationwide surveillance of bacterial respiratory pathogens conducted by the surveillance committee of Japanese Society of Chemotherapy, the Japanese Association for Infectious Diseases, and the Japanese Society for Clinical Microbiology in 2012: General view of the pathogens' antibacterial susceptibility.
    Yanagihara K, Watanabe A, Aoki N, Matsumoto T, Yoshida M, Sato J, Wakamura T, Sunakawa K, Kadota J, Kiyota H, Iwata S, Kaku M, Hanaki H, Ohsaki Y, Fujiuchi S, Takahashi M, Takeuchi K, Takeda H, Ikeda H, Miki M, Nakanowatari S, Takahashi H, Utagawa M, Nishiya H, Kawakami S, Morino E, Takasaki J, Mezaki K, Chonabayashi N, Tanaka C, Sugiura H, Goto H, Saraya T, Kurai D, Katono Y, Inose R, Niki Y, Takuma T, Kudo M, Ehara S, Sato Y, Tsukada H, Watabe N, Honma Y, Mikamo H, Yamagishi Y, Nakamura A, Ohashi M, Seki M, Hamaguchi S, Toyokawa M, Fujikawa Y, Mitsuno N, Ukimura A, Miyara T, Nakamura T, Mikasa K, Kasahara K, Ui K, Fukuda S, Nakamura A, Morimura M, Yamashita M, Takesue Y, Wada Y, Sugimoto K, Kusano N, Nose M, Mihara E, Kuwabara M, Doi M, Watanabe Y, Tokuyasu H, Hino S, Negayama K, Mukae H, Kawanami T, Ota T, Fujita M, Honda J, Hiramatsu K, Aoki Y, Fukuoka M, Magarifuchi H, Nagasawa Z, Kaku N, Fujita J, Higa F, Tateyama M.
    J Infect Chemother; 2017 Sep; 23(9):587-597. PubMed ID: 28669567
    [Abstract] [Full Text] [Related]

  • 10. [In vitro antibacterial activities of cefteram and other beta-lactam agents against recent clinical isolates].
    Yamaguchi K, Ohno A, Takahashi S, Hayashi M, Yamanaka K, Hirakata Y, Mitsuyama J.
    Jpn J Antibiot; 1998 Jan; 51(1):11-25. PubMed ID: 9557273
    [Abstract] [Full Text] [Related]

  • 11. [In vitro antimicrobial susceptibilities and beta-lactamase production of clinical isolates. beta-Lactamase Study Group in Chubu-area].
    Ito Y, Kanematsu M, Yura J, Ueno K, Watanabe K.
    Jpn J Antibiot; 1994 Jan; 47(1):11-21. PubMed ID: 8114269
    [Abstract] [Full Text] [Related]

  • 12. Screening extended-spectrum beta-lactamase production in Enterobacter cloacae and Serratia marcescens using antibiogram-based methods.
    Su PA, Wu LT, Cheng KC, Ko WC, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2010 Feb; 43(1):26-34. PubMed ID: 20434120
    [Abstract] [Full Text] [Related]

  • 13. [Susceptibilities of bacteria isolated from patients with lower respiratory infectious diseases to antibiotics (1997)].
    Ikemoto H, Ito C, Yoshida T, Watanabe K, Mori T, Ohno I, Okada S, Igari J, Arakawa M, Igarashi K, Oguri T, Okada M, Ozaki K, Terai T, Aoki N, Inoue H, Nakadate T, Kitamura N, Sekine O, Suzuki Y, Ando M, Suga M, Sato K, Nakata K, Kusano N.
    Jpn J Antibiot; 1999 May; 52(5):353-97. PubMed ID: 10480048
    [Abstract] [Full Text] [Related]

  • 14. In vitro antibacterial activities of ticarcillin alone and ticarcillin plus clavulanic acid against beta-lactamase producing and non-producing microorganisms.
    Hsueh PR, Chang SC, Chen YC, Hsu LY, Luh KT, Hsieh WC.
    Zhonghua Min Guo Wei Sheng Wu Ji Mian Yi Xue Za Zhi; 1992 Aug; 25(3):149-59. PubMed ID: 1342000
    [Abstract] [Full Text] [Related]

  • 15. Effect of beta-lactamase expression on susceptibility of local isolates of Enterobacter cloacae, Serratia marcescens and Pseudomonas aeruginosa to beta-lactam antibiotics.
    Ramadan MA, Tawfik AF, Shibl AM.
    Chemotherapy; 1995 Aug; 41(3):193-9. PubMed ID: 7656665
    [Abstract] [Full Text] [Related]

  • 16. In vitro activity of avibactam (NXL104) in combination with β-lactams against Gram-negative bacteria, including OXA-48 β-lactamase-producing Klebsiella pneumoniae.
    Aktaş Z, Kayacan C, Oncul O.
    Int J Antimicrob Agents; 2012 Jan; 39(1):86-9. PubMed ID: 22041508
    [Abstract] [Full Text] [Related]

  • 17. Prevalence of antimicrobial-resistant pathogens in Canadian hospitals: results of the Canadian Ward Surveillance Study (CANWARD 2008).
    Zhanel GG, DeCorby M, Adam H, Mulvey MR, McCracken M, Lagacé-Wiens P, Nichol KA, Wierzbowski A, Baudry PJ, Tailor F, Karlowsky JA, Walkty A, Schweizer F, Johnson J, Canadian Antimicrobial Resistance Alliance, Hoban DJ.
    Antimicrob Agents Chemother; 2010 Nov; 54(11):4684-93. PubMed ID: 20805395
    [Abstract] [Full Text] [Related]

  • 18. Development of a multiplex PCR and SHV melting-curve mutation detection system for detection of some SHV and CTX-M beta-lactamases of Escherichia coli, Klebsiella pneumoniae, and Enterobacter cloacae in Taiwan.
    Chia JH, Chu C, Su LH, Chiu CH, Kuo AJ, Sun CF, Wu TL.
    J Clin Microbiol; 2005 Sep; 43(9):4486-91. PubMed ID: 16145096
    [Abstract] [Full Text] [Related]

  • 19. [Antimicrobial activities of sulbactam/ampicillin against clinically isolated microbial strains].
    Deguchi K, Yokota N, Koguchi M, Suzuki Y, Fukayama S, Ishihara R, Oda S, Tanaka S, Nakane Y, Fukumoto T.
    Jpn J Antibiot; 1995 Apr; 48(4):529-47. PubMed ID: 7783316
    [Abstract] [Full Text] [Related]

  • 20. In vitro activity of tigecycline against clinical isolates of extended-spectrum beta-lactamase-producing Klebsiella pneumoniae, Serratia marcescens and Enterobacter cloacae.
    Ku YH, Chuang YC, Yu WL.
    J Microbiol Immunol Infect; 2008 Aug; 41(4):332-6. PubMed ID: 18787741
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.